Ken Griffin Cv Rx, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 9,000 shares of CVRX stock, worth $78,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,000
Previous 15,300
41.18%
Holding current value
$78,210
Previous $278,000
61.51%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CVRX
# of Institutions
75Shares Held
13.5MCall Options Held
49.9KPut Options Held
2.1K-
Johnson & Johnson New Brunswick, NJ4.1MShares$35.7 Million16.99% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$20.6 Million2.68% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA664KShares$5.77 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT587KShares$5.1 Million0.71% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $179M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...